AtlantiCann Medical Inc. is a premium cannabis licensed producer based in Nova Scotia, Canada. Founded in 2013, the company prides itself on offering premium craft cannabis with boutique genetics, handcrafted in a non-irradiated process. Each cultivar is grown in a controlled environment that adheres to high-quality assurance protocols, and every batch undergoes third-party lab testing by Health Canada approved laboratories for cannabinoid potency (THC, CBD), terpenes, as well as microbial and chemical contaminants. With a slogan of "Premium Cannabis Licensed Producer in Nova Scotia. Boutique Genetics, Craft Quality, Terpene rich. EUGMP Certified," AtlantiCann Medical aims to provide top-notch cannabis products to its customers. Although specific details about the last investment and investors are not available, the company's dedication to quality and craftmanship in the cannabis industry positions it as a potentially interesting prospect for venture capital investment within the lifestyle sector.
There is no investment information
No recent news or press coverage available for AtlantiCann Medical Inc..